September 24, 2021

To, Dy. General Manager Department of Corporate Services, BSE Ltd., P. J. Towers, Dalal Street, Fort, Mumbai - 400 001.

To,

The Manager - Listing, National Stock Exchange of India Ltd., Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051.

Ref: Scrip Code: 532296

Ref: Scrip Name: GLENMARK

Dear Sirs,

Sub: Proceedings and Scrutinizer's Report of the 43rd Annual General Meeting (AGM} of Glen mark Pharmaceuticals Limited ('the Company'} held on September 24, 2021

The 43rd AGM of the Company was held on Friday, September 24, 2021 at 2.00 p.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) and the webcast facility was provided to the members.

In this regards, please find enclosed the following:

1. Summary of the proceedings of the AGM of the Company as required under Regulation 30, Para A of Schedule - Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. ('Listing Regulations') - Annexure A.
1. Voting results of the business transacted at the AGM, as required under Regulation 44 (3) of the Listing Regulations has been filed in XBRL Mode.
1. Report of the Scrutinizer pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 of today's date - Annexure B. The Scrutinizer's Report is made available on the Company's website at www.glenmarkpharma.com

This is for your Information and records.

Thanking You,

Yours Faithfully, For Glenmark Pharmaceuticals Ltd.

Harish Kuber Company Secretary & Compliance Officer

Annexure A

Summary of Proceedings of the 43rd Annual General Meeting

The 43rd Annual General Meeting ('AGM') of the members of Glenmark Pharmaceuticals Limited ('the Company') was held on Friday, September 24, 2021 at 2:00 p.m. (1ST) via Video Conferencing ('VC')/ OVAM. In compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, the webcast facility was also provided to the shareholders. The said AGM commenced at 2.00 p.m. and concluded at 3.31 p.m.

Mr. Glenn Saldanha, Chairman & Managing Director presided over the meeting and welcomed the members and directors participating through video conference. The representatives of M/s Suresh Surana & Associates LLP, Statutory Auditors and S. S. Rauthan & Associates, Secretarial Auditors and Scrutinizers, were also present at the Meeting through VC.

The requisite quorum being present, the Chairman called the Meeting to order. The Registers as required under the Companies Act, 2013 and other relevant documents mentioned in the Notice were available for inspection. Since there was no physical attendance of Members and in compliance with the Circulars issued by MCA and SEBI, the requirement of appointing proxies was not applicable, except for the authorized representatives of corporate shareholders.

With the consent of the Members, the Notice of the Meeting was taken as read. The Members were informed that the Statutory Auditors' Report and Secretarial Audit Report did not have any qualifications.

The Chairman delivered his speech covering Business Environment, Performance Overview, Innovation, Update on lchnos Sciences & Glenmark Life Sciences, Quality and Compliance, Impact beyond Business, etc.

The Company Secretary informed the Members that the Company had provided its Members the facility to cast their vote electronically through the National Securities Depository Limited ('NSDL') system before the Meeting. He also informed that the remote e-voting facility was also made at the AGM for the benefit of Members who were present during the Meeting and had not cast their votes earlier through remote e-voting.

The Company Secretary further informed about the appointment of Mr. Surjan Singh Rauthan, Practicing Company Secretary as the Scrutinizer to conduct the e-voting process in a fair and transparent manner pursuant to the provisions of section 109 of the Companies Act, 2013.

The following resolutions set out in the Notice convening the AGM were put to vote by remote e-voting and remote e-voting at the Meeting:

Res. No.	Resolution
	Ordinary Business
1	To receive, consider, approve and adopt the Audited Standalone Financial Statements for the Financial Year ended 31 March 2021 together with the reports of the Board and Auditors thereon
2	Consolidated Financial To receive, consider, approve and adopt the Audited Statements for the Financial Year ended 31 March 2021 together with the report of the Auditors thereon
3	To declare dividend on Equity Shares
	Special Business
4	To appoint a Director in place of Mrs. Blanche Sa Idanha (DIN 00007671) who retires by rotation and being eligible, offers herself for re-appointment as per Section 152(6) of the Companies Act, 2013
5	To ratify remuneration of the cost auditor for the financial year ending 31 March 2022

Mr. Glenn Saldanha, Chairman & Managing Director then invited the Members to express their views, ask questions and seek clarifications on the operations and financial performance of the Company and on the resolutions set out in the Notice. Company had received requests from 6 members to speak during the AGM. After giving sufficient time to all the speaker members, Mr. Glenn Saldanha, Chairman & Managing Director and Mr. V. S. Mani, Executive Director & Global CFO appropriately responded to the queries raised by them.

Mr. Glenn Sa Idanha further informed the Members that the combined results of the remote e-voting before as well as remote e-voting during the AGM would be announced within 2 working days of the conclusion of the Meeting and the results along with the Scrutinizer's Report would be intimated to the Stock Exchanges in terms of the Listing Regulations and would be placed on the websites of the Company.

The Chairman then thanked the Members for their continued support and for attending and participating in the Meeting. He also thanked-the Directors for joining the Meeting virtually. The evoting facility was kept open for 30 minutes to enable the members to cast their vote. Upon completion of thee-voting process the Meeting was declared as closed.

Yours Faithfully, For Glen mar Pharmaceuticals Limited

Haris uber

Company Secretary & Compliance Officer

S. S. Rauthan & Associates

Company Secretaries

cs Surjan Singh Rauthan B Com FC.S

SCRUTINIZER'S REPORT

[Pursuant to Section 108 of the Companies Act, 2013 and rule 20 (4) (xii) of the Companies (Management and Administration) Rules, 2014 read with amendments made thereto and Regulation 44 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015)

To, The Chairman Glenmark Pharmaceuticals Limited (CIN: L24299MH 1977PLC019982) B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mahalaxmi, Mumbai - 400026

Dear Sir,

1. I, Surjan Singh Rauthan (C.P.3233), Practicing Company Secretary, Proprietor of Mis S. S. Rauthan & Associates, Company Secretaries(UIN:S1999MH2026900), has been appointed as a Scrutinizer by the Board of Directors of Glenmark Pharmaceutical Limited (herein after referred as "the Company") at its meeting held on May 28, 2021 for the purpose of scrutinizing the remote e-Voting and voting through electronic voting system during the Annual General Meeting ('AGM') and ascertaining the requisite majority on remote e-Voting and voting through electronic voting system during the Annual General Meeting carried out as per the provisions of Section 108 of the Companies Act, 2013 ('the Act') read with Rule 20 of the Companies (Management and Administration) Rules, 201 4 read with amendments made thereto and Regulation 44 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and applicable on the businesses contained in the Notice of the 43rd Annual Gener~Meeting (AGM) of the Company held on Friday, September 24, 2021 at 2:00 p.m. 1ST through two-way Video Conferencing (VC) facility I Other Audio Visual Means (OAVM) facility.
1. The management of the Company is responsible to ensure the compliance with the requirements of the Companies Act, 2013 ("The Act"), Rules and notifications relating to

S. S. Rauthan .& Associates Company Secretaries BS

I! Surjan Sir,gh Rauthan B.Com .. F.C.S

the Notice of the 43rd Annual General Meeting of the Members of the Company. My responsibility as a Scrutinizer for the remote e-Voting and electronic voting through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") during the AGM is restricted in making a Scrutinizer's Report of the votes cast "IN FAVOUR" or "AGAINST" the businesses set out in the Notice, based on the report generated from the electronic voting system provided by National Securities Depository Limited (NSDL), engaged by the Company to provide remote e-voting and the electronic voting during the 43rd AGM of the Company held on Friday, September 24, 2021 at 2.00 p.m. (1ST) through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM") facilities .

1. Further to above. I submit my report as under:
3.1 The Company has provided the e-voting facility through National Securities Depository Limited (NSDL) website www.evoting.nsdl.com. The Company had uploaded Notice of 43rd AGM and the Annual Report for the FY 2021 on the Company's website www.glenmarkpharma.com and also on the website of Stock Exchanges i.e BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com respectively and also on the website of NSDL i.e. www.evoting.nsdl.com to facilitate its members to cast their vote through e-voting.
3.2 The Annual Report along with the 43rd AGM otice was sent electronically only to those Members who had registered their email addresses with the Depository Participants / Registrar and Share Transfer Agent (RTAs) i.e. KFin Technologies Private Limited ('KFintech') (formerly known as Karvy Fintech Private Limited) •'""':.upto the cut-off date for sending the AGM notice i.e. August 20, 2021 .
3.3 As prescribed in the Rules and General Circulars issued by the MCA, the Company has also published advertisements in newspapers on August 25, 2021 and August 29, 2021 in "Financial Expre~s", (in English) and in "Loksatta" (in Marathi) and it carried all reqy{ed infor tion as specified in the said rules and notifications.

Page 2 of 6

Practicing Since 1999

CELEJJRATING th - - --__ - ----_ ---- ---- -------------- tn" 703, NavJ1van Commercial Premises Co-op. Soc Ltd., Lammgton Road , Mumbai - 400 008. 'fJl'NIVERSARY Tel. : :91-22-2301 2626 • Tel~fa~ :_ 91 -22-2309 1275 • Mob. · +91 -99874 45899 / 84528 65509 E-mail . [email protected] / [email protected] •Website : www.ssrgroup1nd1a.1n

S. S. Rauthan & Associates Company Secretaries OS

cs Surjan Sin h Rauthan

B.Com . F.C S
3.4 The Members of the Company as on the "Cut-off' date i.e. Friday, September 17, 2021 were entitled to vote on the businesses (item nos. 1 to 5) as set out in the Notice of the 43rd AGM dated May 28, 2021 .
3.5 The Chairman at the 43rd AGM , held on Friday, September 24, 2021 through twoway Video Conference (VC) / Other Audio Visual Means (OAVM) announced that Members who have not exercised their votes through remote e-Voting may, exercise their votes through e-voting system provided during the meeting.
3.6 The remote e-voting commenced from Tuesday, September 21 , 2021 (9.00 a.m. 1ST) and concluded on Thursday, September 23, 2021 (5.00 p.m. 1ST) and the NSDL e-voting platform was blocked thereafter.
3.7 After the closure of the remote e-voting , the voting platform was kept opened during the AGM, the report on remote e-voting was diligently scrutinized.
3.8 On completion of remote e-voting and e-voting during the AGM by the members, the voting facility was unblocked. I have scrutinized and reviewed the remote evoting and e-voting during the AGM and votes tendered therein based on the data downloaded from the NSDL e-voting system.
3.9 My consolidated report on the results of voting through remote e-voting and e-voting during the AGM is as under:

Page 3 of 6

Practicing Since 1999

.......

CELEBRATING th tn' 703, Navjivan Commercial Premises Co-op. Soc Ltd .. Lammgton Road, Mumbai - 400 008 'fJf'NIVERSARY Tel. · ~91 -22-2301 2626 • Tel~fax. :_ ⁹¹ -22-2309 _1275 •Mob.· +91 -99874 45899 / 84528 65509 E-mail : [email protected] I [email protected] • Website : www.ssrgroupmdia.in

S. S. Rauthan & Associates IJS

. Surjan Sin h Rauthan

B Com , F.CS Item No.1 - As an Ordinary Resolution:

To receive, consider, approve and adopt the Audited Standalone Financial Statements for the Financial Year ended March 31 , 2021 together with the reports of the Board and Auditors thereon.

No. or Equity Shares held	No. or valid votes cast	No. of members	No. of votes in 11FavourH	No. of members	No. of votes "Against''	% of votes
		voted In .,FavourJt		voted "Against"		Favour	Against
220648594	220570088	1592	220568112	37	1976	99.9991	0.0009

Item No.2 - As an Ordinary Resolution:

To receive, consider, approve and adopt the Audited Consolidated Financial Statements for the Financial Year ended March 31, 2021 together with the report of the Auditors thereon.

No. of Equity Shares held	No. of valid votes cast	No. of members	No. of votes in uFavour"'	No. of members	No. of votes "Against"	% of votes
		voted in "Favour"		voted "Against''		Favour	Against
220644267	220565761	1574	220563217	40	2544	99.9988	0.001 2

Item No.3 - As an Ordinary Resolution:

To declare dividend on Equity Shares.

No. of Equity Shares held	No, of valid votes cast	No. of members	No. of votes in 11Favour"	No. of members	No. of votes "Against•·	% of votes
		voted in 11Favour"		voted "Against"		Favour	Against
2221 43685	222065179	1587	222063395	31	1784	99.9992	0.0008
-~

Page 4 of 6

703, Navjivan Commercial Premises Co-op. Soc ltd., Lamington Road , Mumbai - 400 008. Tel. : +91 -22-2301 2626 ·Telefax. : 91-22-2309 1275 • Mob. : +91-99874 45899 / 84528 65509 E-mail : [email protected] I [email protected] • Website : www.ssrgroupindia in

S. S. Rauthan .& Associates IJS

Company Secretaries

118 Surfan Singh Rauthan B.Com., FC.S

Item No.4 - As a Special Resolution:

To appoint a Director in place of Mrs. Blanche Saldanha (DIN 00007671) who retires by rotation and being eligible, offers herself for re-appointment as per Section 152(6) of the Companies Act, 2013

No. of Equity Shares held	No. of valid votes cast	No. of members	No. of votes In II Favour" •	No. of members	No. of votes "Against"	% of votes
		voted In °Favour"		voted "Against•		Favour	Against
220780766	220081238	1314	189305536	285	30775702	86.0162	13.9838

Item No.5 - As an Ordinary Resolution:

Ratification of remuneration of M/s Sevekari Khare & Associates, Cost Auditor of the Company

No. of Equity Shares held	No. of valid votes cast	No. of members	No. of votes In " Favour"	No. of members	No. of votes "Against"	% of votes
		voted In 11Favourn		voted "Against"		Favour	Against
222142981	222064381	1517	222058886	89	5495	99.9975	0.0025

1. We observed that :
a) 1615 Members had cast their votes through remote e-voting
b) 15 Members had cast their votes during the AGM.
1. All the relevant records of e-voting is under my safe custody until the Chairman of the Company considers, approves and signs the minutes of the 43rd AGM and the same shall be ha'rftJed over thereafter to the Company Secretary of the Company for safe keeping.
1. Based on the aforesaid results, we report that Four (4) Ordinary Resolutions as set out under Item Nos. 1, 2, 3 and 5 and One ( 1) Special Resolution as set out in Item No.4 of the Notice of the 43rd AGM dated May 28, 2021 have been passed with the requisite majority.

Page 5 of 6

Practicing Since 1999

CEU8.RA11NG ~ - - --.. -------------- ---------=------ tn 703, NavJ1van Commercial Premises Co-op . Soc. Ltd ., Lamington oad , Mumbai_ 400 008. IJJiNIVERSARY Tel. : :~1-22-2301 2626 • Tel~fa~ ·_ ⁹¹ -22-2309 _1275 • Mob.: +91 -99874 45899 / 84528 65509 E-mail . [email protected] I [email protected] •Website : www.ssrgroupindia.1n

^S . S . Rauthan & Associates OS

Company Secretaries

cs Sur;an Sin h Rauthan

B.Com .. F.C.S 7. You may accordingly declare the result of remote e-voting and e-voting during the

Thanking you,

Yours faithfully, For S n & Associates cretaries

U H202690

Place : Mumbai Date : September 24, 2021

. ....., '

43rd AGM .

i ingh Rauthan f Proprietor '·· M. No. FCS.-4807 C.O.P. No.: 3233 UDIN: F004807C000998327 Scrutinizer for Remote e-voting and e-voting at 43rd AGM

Countersigned

Mr. Harish Kuber Company Secretary & Compliance Officer

Page 6 of 6

Practicing Since 1999

th 703, Navjivan Commercial Premises Co-op. Soc Ltd., Lamington Road, Mumbai - 400 008. 'NIVERSARY Tel. : +91 -22-2301 2626 • Telefax .. 91-22-2309 1275 • Mob. : +91 -99874 45899 / 84528 65509 E-mail : [email protected] / [email protected] • Website : www.ssrgroupindia.in

Consolidated Voting Result (i.e. Remote e-voting and e-voting during the 43rd Annual General Meeting) of Glenmark Pharmaceuticals Limited, in accordance w ith Regu lation 44(3) of SEBI LODR

			GLENMARK PHARMACEUTICALS LIMITED
Date of the AGM/EGM			24-09-2021
Total number of shareholders on			332808
No. of shareholders present in the			Not applicable
		meeting either in person or through
proxy:								For S. S. Rauthan & Associates
Promoters and Promoter Group:			Not applicable					Company Secretaries,
Public:			Not applicable
No. of Shareholders attended the		meeting through Video Conferencing						Surjan Singh Rauthan	Proprietor
Promoters and Promoter Group:			$\overline{4}$					C.P. No. 3233 MN-FCS-4807
Public:			111
Resolution No.	$\vert$ 1
Resolution required: Ordinary			2021 together with the reports of the Board and Auditors thereon				To receive, consider, approve and adopt the Audited Standalone Financial Statements for the Financial Year ended March 31,
			Whether promoter/ promoter group are interested in the agenda/resolution : No
Category	Mode of Voting	No. of shares held	No. of votes polled	% votes polled on outstanding	No. of votes in favour	No. of votes - in Against	% of votes - in favour	% of votes - in Against

		(1)	(2)	shares $(3)$ =	(4)	(5)	$(6)=[(4)/(2)]*100$	$(7)=[(5)/(2)]*100$
Promoter	E-voting		131585687	$[(2)/(1)]$ *100 100	131585687		100.0000
and	Poll			$\Omega$
Promoter	Postal Ball	131585687		$\sqrt{ }$			$\sim$
Group	Total	131585687	131585687	100	131585687	$\bf{0}$	100.0000
	E-voting		82839143	82.8713	82839143		100.0000
	Poll		0
Public	Postal Ball	99961151	$\Omega$
Institutions	Total	99961151	82839143	82.8713	82839143	$\bf{0}$	100.0000
	E-voting		6145258	12.1397	6143282	1976	99.9678	0.0322
	Poll		$\Omega$ $\Omega$						C.P. N ₀ 8233
Public Non- Postal Ball Institutions	Total	50621318 50621318	6145258	12.1397	6143282	1976	99.9678	0.0322

Consolidated Voting Result (i.e. Remote e-voting and e-voting during the 43rd Annual General Meeting) of Glenmark Pharmaceuticals Limited, in accordance with Regulation 44(3) of SEBI LODR

	GLENMARK PHARMACEUTICALS LIMITED
Date of the AGM/EGM	24-09-2021

Resolution No. 2

Resolution required: To receive, consider, approve and adopt the Audited Consolidated Financial Statements for the Financial Year ended March 31 , 2021 together with the report of the Auditors thereon

Ordinarv

Whet h er promoter/ promoter group are interested in the agenda/resolution : No

Category	Mode of Voting	No. of shares held	No. of votes polled	% votes polled on outstanding shares	No. of votes - in favour	No. of votes - in Against	% of votes - favour	in % of votes - in Against
		(1)	(2)	(3)= [(2)/(1)]*100	(4)	(5)	0	(6)=[(4)/(2))10 (7)=[(5)/(2))10 0
	E-voting		131585687	100.0000	131585687	0	100.0000	-
	Poll		0	-	0	0	-	-
	Promoter and Postal Ballot(if applicable)	131585687	0	-	0	0	-	-
Promoter Group	Total	131585687	131585687	100.0000	131585687	0	100.0000	-
	E-voting		82839143	82.8713	82839143	0	100.0000	-
	Poll		0	-	0	0	-	-
Public	Postal Ballot(if applicable)	99961151	0	-	0	0	-	-
Institutions	Total	99961151	82839143	82.8713	82839143	0	100.0000	-
	E-voting		6140931	12.1311	6138387	2544	99.9586	0.0414
	Poll		0	-	0	0	-	-
Public Non-	Postal Ballot(if aoolicable)	50621318	0	-	0	0	-	-
Institutions	Total	50621318	6140931	12.1311	6138387	2544	99.9586	0.0414
Total		282168156	220565761	78.1682	220563217	2544	99.9988	0.0012

. . No. 3233 MN-FCS-4807

· n SiQgh Rauthan · Proprietor

Consolidated Voting Result (i.e. Remote e-voting and e-voting during the 43rd Annual General Meeting) of Glenmark Pharmaceuticals Limited, in accordance with Regulation 44(3) of SEBI LODR

	LIMITED $\cdots$ GLI PHARMAC ENMARK $\Delta$
-GM Date of the AGM/F	$\sim$ $\sim$ $\cdots$

Resolution No.
Resolution	To declare dividend on Equity Shares
required:
Ordinary

Whether promoter/ promoter group are interested in the agenda/resolution : No

Category	Mode of Voting	No. of shares held	No. of votes polled	% votes polled on outstanding shares	favour	No. of votes - in No. of votes - in Against	% of votes - in favour	% of votes - in Against
		(1)	(2)	$(3)=$ $[(2) / (1)]$ *100	(4)	(5)	$ (6)=[(4)/(2)]^100 (7)=[(5)/(2)]^100 $
	E-voting		131585687	100.0000	131585687		100.0000
	Poll
Promoter and	Postal Ballot(if applicable)	131585687
Promoter Group	Total	131585687	131585687	100.0000	131585687	$\Omega$	100.0000
	E-voting		84338574	84.3714	84338574		100.0000
	Poll
Public	Postal Ballot(if applicable)	99961151
Institutions	Total	99961151	84338574	84.3714	84338574	$\mathbf{0}$	100.0000
	E-voting		6140918	12.1311	6139134	1784	99.9709	0.0291
	Poll
Public Non-	Postal Ballot(if applicable)	50621318
Institutions	Total	50621318	6140918	12.1311	6139134	1784	99.9709	0.0291
Total		282168156	222065179	78.6996	222063395	1784	99.9992	0.0008

L '

urjan Si!)gh Rauthan · Proprietor

C.P. No. 3233 MN-FCS-4801

Consolidated Voting Result (i.e. Remote e-voting and e-voting during the 43rd Annual General Meeting) of Glenmark Pharmaceuticals Limited, in accordance with Regulation 44(3) of SEBI LODR

	GLENMARK PHARMACEUTICALS LIMITED
Date of the AGM/EGM	24-09-2021

Resolution No. 4
Resolution	To appoint a Director in place of Mrs. Blanche Saldanha (DIN 00007671) who retires by rotation and being eligible, offers herself for re-appointment as
required:	per Section 152(6) of the Companies Act, 2013
Soecial

Whether promoter/ promoter group are interested in the agenda/resolution : No

Category	Mode of Voting	No. of shares held	No. of votes polled	% votes polled on outstanding shares	No. of votes - favour	in No. of votes - in Against	% of votes - in favour	% of votes - in Against
		(1)	(2)	(3)= ((2)/(1 )]*100	(4)	(5)		(6)=((4)/(2)]"100 (7)=[(5)/{2)]*100
	E-voling		130475360	99.1 562	130475360	0	100.0000	-
	Poll		0	-	0	0	-	-
	Promoter and Postal Ballot(if applicable)	131585687	0	-	0	0	-	-
Promoter Group	Total	131585687	130475360	99.1562	130475360	0	100.0000	-
	E-votinq		83469174	83.5016	52704918	30764256	63.1430	36.8570
	Poll		0	-	0	0	-	-
Public	Postal Ballot(if applicable)	99961151	0	-	0	0	-	-
Institutions	Total	99961151	83469174	83.5016	52704918	30764256	63.1430	36.8570
	E-voting		6136704	12.1 228	6125258	11446	99.8135	0.1865
	Poll		0	-	0	0	-	-
Public Non-	Postal Ballot(if applicable)	50621318	0	-	0	0	-	-
Institutions	Total	50621318	6136704	12.1228	6125258	11446	99.8135	0.1865
Total		282168156	220081238	77.9965	189305536	30775702	86.0162	13.9838

Associates ·es, ~~ ....... ~an Sir;gh Rauthan · · Proprietor · · No. 3233 MN-FCS-4807

Consolidated Voting Result (i.e. Remote e-voting and e-voting during the 43rd Annual General Meeting) of Glenmark Pharmaceuticals Limited, in accordance with Regulation 44(3) of SEBI LODR

	GLENMARK PHARMACEUTICALS LIMITED
Date of the AGM/EGM	24-09-2021

Resolution No. 5
Resolution	Ratification of remuneration of Mis Sevekari Khare & Associates, Cost Auditor of the Company
required:
Ordinarv

Whether promoter/ promoter group are interested in the agenda/resolution : No

				% votes polled
		No. of shares	No. of votes	on outstanding No. of votes -	in	No. of votes - in	% of votes - in	% of votes - in
Cater:iorv	Mode of Voting	held	polled	shares	favour	Against	favour	Against
				(3)=
		(1)	(2)	[(2)/(1)]"1 00	(4)	(5)		(6)=[(4)/(2)]100 (7)=[(5)/(2)]100
	E-voting		131585687	100.0000	131585687	0	100.0000	-
	Poll		0	-	0	0	-	-
	Promoter and Postal Ballot(if applicable)	131585687	0	-	0	0	-	-
Promoter Group	Total	131585687	131585687	100.0000	131585687	0	100.0000	-
	E-votinQ		84338574	84.3714	84338574	0	100.0000	-
	Poll		0	-	0	0	-	-
Public	Postal Ballot(if applicable)	99961151	0	-	0	0	-	-
Institutions	Total	99961151	84338574	84.3714	84338574	0	100.0000	-
	E-voting		6140120	12.1295	6134625	5495	99.9105	0.0895
	Poll		0	-	0	0	-	-
Public Non-	Postal Ballot(if applicable)	50621318	0	-	0	0	-	-
Institutions	Total	50621318	6140120	12.1295	6134625	5495	99.9105	0.0895
Total		282168156	222064381	78.6993	222058886	5495	99.9975	0.0025

s· gh Rauthan 1an ,9 . Proprietor N 3233 MN-FCS-4807 c.P. o.

AI assistant

Glenmark Pharmaceuticals ltd Regulatory Filings 2021

62608_rns_2021-09-24_e3f1fa4a-6eaf-4781-aa40-d3d209819291.pdf

Annexure A

Summary of Proceedings of the 43rd Annual General Meeting